Document Detail

Myasthenia gravis in the elderly.
MedLine Citation:
PMID:  1262678     Owner:  NLM     Status:  MEDLINE    
During a 15-year period in Jerusalem, myasthenia gravis was diagnosed in 15 patients aged 60 or older. At this age, diagnosis is difficult because of such possible associated conditions as cerebrovascular and cardiovascular arteriosclerotic diseases or bronchopulmonary disorders. The clinical course often is complicated by these associated conditions, and also by their treatment. Seven of the patients died within 4 years of the onset of their illness, but only 5 because of myasthenia gravis. This disease represents an important diagnostic and therapeutic problem in elderly patients.
Y Herishanu; O Abramsky; S Feldman
Related Documents :
19278738 - Association of hla-a in autoimmune myasthenia gravis with thymoma.
20737498 - Clinicopathological aspects of mucosa-associated lymphoid tissue (malt) lymphoma of the...
6370908 - Thymectomy in myasthenia gravis. a review.
1255208 - Genetic associations between myasthenia gravis and the hl-a system.
1244288 - The spirographic "kink". a sign of emphysema.
21899998 - Inflammatory activity assessment by f18 fdg-pet/ct in persistent symptomatic sarcoidosis.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of the American Geriatrics Society     Volume:  24     ISSN:  0002-8614     ISO Abbreviation:  J Am Geriatr Soc     Publication Date:  1976 May 
Date Detail:
Created Date:  1976-07-06     Completed Date:  1976-07-06     Revised Date:  2008-03-10    
Medline Journal Info:
Nlm Unique ID:  7503062     Medline TA:  J Am Geriatr Soc     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  228-31     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / adverse effects,  therapeutic use
Child, Preschool
Middle Aged
Myasthenia Gravis / complications,  diagnosis*,  drug therapy
Neostigmine / therapeutic use
Prednisone / therapeutic use
Pyridostigmine Bromide / therapeutic use
Reg. No./Substance:
0/Anti-Bacterial Agents; 101-26-8/Pyridostigmine Bromide; 53-03-2/Prednisone; 59-99-4/Neostigmine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The care of decubitus ulcers pressure sores.
Next Document:  Immunisation of sheep against Schistosoma mattheei using either irradiated cercariae or irradiated s...